Cmdr. John B. Cason, M.D., who will lead an upcoming Tri-Service study on the benefits of SMILE laser vision correction for patients working in extreme environments and dynamic roles unique to service members and first responders, performed the first minimally-invasive SMILE treatments for the U.S. Navy on Thursday April 6, 2017 at the Navy Refractive Surgery Center San Diego.
ZEISS ReLEx SMILE provides a new laser vision correction option for U.S. service members who serve in physically demanding and dynamic roles where excellent visual acuity is critical. Dr. Bruce Rivers performed the first SMILE minimally-invasive laser eye surgery procedure for the U.S. Department of Defense at Fort Belvoir Community Hospital in Virginia on Thursday March 16, 2017.
Carl Zeiss Meditec announces the first ReLEx® SMILE minimally-invasive laser eye surgery procedure has been performed in the United States with the ZEISS VisuMax femtosecond laser by Dr. Jon G. Dishler at the Dishler Laser Institute in Greenwood Village, Colorado.
ZEISS continues to set the pace in OCT innovation with Swept-Source OCT imaging that expands the potential for clinical researchers to open new frontiers of discovery in diseases affecting the retina. ZEISS PLEX Elite 9000 allows the potential to see deeper, wider and in more detail from vitreous to sclera than previously possible with other technologies.
The Medical Technology Business Group of ZEISS continues to strengthen its leadership team with the appointment of distinguished refractive surgeon and clinical professor of ophthalmology, Steven C. Schallhorn, MD as Chief Medical
Innovations from ZEISS for glaucoma, cataract surgery, eye care data management, laser vision correction and basic diagnostics at the AAO 2013 in New Orleans
The Medical Technology Business Group of ZEISS has appointed Andrew Ihan Chang to lead its worldwide sales organization for the newly consolidated Strategic Business Unit Global Ophthalmic Devices.
The Medical Technology Business Group of ZEISS announces the introduction in the US of the VisuMax® Small Incision Lenticule Extraction (SMILE) procedure, the latest advancement in refractive surgery for the correction of myopia.
Carl Zeiss Meditec AG consolidates its ophthalmology activities in a single Strategic Business Unit; James V. Mazzo will head the new ophthalmology division.
ZEISS Cataract Suite markerless has shown in recent clinical studies to support surgeons in achieving excellent refractive outcomes with post-operative refractive cylinder within +/- 0.50D (diopters) for up to 99% of patients.
New Swept-Source OCT technology platform from ZEISS empowers leading clinical experts around the world to expand discovery in clinical research for retina.
ZEISS introduces a new generation of high resolution Fundus cameras at the American Academy of Ophthalmology (AAO) in Las Vegas.
At the 2015 Annual Meeting of the American Academy of Ophthalmology (AAO) in Las Vegas, ZEISS announces innovations for clinical excellence and practice performance in ophthalmology.
AngioPlex OCT Angiography from ZEISS is the next generation of vascular imaging, providing non-invasive 3D images of blood flow in the eye to help eye care professionals detect retinal diseases earlier and improve treatment and management of these diseases
Prolific research from ZEISS Medical Technology at the recent 2015 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting in Denver highlights the company’s standing as the leader in OCT technology and innovation
At the 2015 American Society of Cataract and Refractive Surgery (ASCRS) Annual Symposium in San Diego, ZEISS Medical Technology highlights its new Humphrey® Field Analyzer 3 as part of the Glaucoma Suite, a connected solution for accurate diagnosis and confident disease management. The company also presents integrated systems that improve and streamline ophthalmic surgery with the ZEISS Cataract Suite markerless and the RESCAN™700 intraoperative OCT.
New HFA3 offers gold-standard perimetry performance with technological advances – such as automated trial lens correction – that are designed to save time and reduce errors, plus test results equal to and interchangeable with test results from previous Humphrey perimeters.
Oraya Therapy represents an attractive new treatment option for patients
The medical technology company ZEISS was the first to introduce a surgical microscope and the first to commercially offer OCT for ophthalmic applications. By merging two gold standards into one system, ZEISS has created another first: a surgical microscope with integrated intraoperative OCT, the OPMI LUMERA® 700 and RESCAN™ 700. Now available in the Unites States, RESCAN 700 provides ophthalmic surgeons the highest-quality intraoperative OCT visualization of the eye without any interruption of surgery.
Innovations from ZEISS in key diagnostic and surgical areas at the 2014 American Academy of Ophthalmology (AAO) meeting in Chicago, including a comprehensive line of basic diagnostics / Additional distribution channel for cataract surgery products
Suite combines gold-standard biometry and visualization products with new technology – recently cleared by the FDA – that eliminates the need to mark the cornea for optimal IOL placement
Truly integrated and clinically proven systems from ZEISS in focus at the 2014 ASCRS in Boston.
Acquisition of US-based manufacturer of Intraocular Lenses (IOLs) Aaren Scientific further expands comprehensie offering in surgical ophthalmoloy
5-year results of international TARGIT-A clinical trial support targeted intraoperative radiotherapy (TARGIT) delivered with the ZEISS INTRABEAM as non-inferior to external beam radiotherapy (EBRT) for selected early stage breast cancer patients.
FORUM Glaucoma Workplace from ZEISS brings together exam data and analysis in new clinically relevant ways to aid in the diagnosis and management of glaucoma
Expanded applications of ZEISS INTRABEAM receive approval in USA, Europe and China
Agreement between ZEISS and leading distributor Henry Schein allows US dentists to easily incorporate into their practice premium dental microscopes and loupes for improved patient care
Two ZEISS gold standard technologies combine with the innovative CALLISTO eye OR management system providing greater efficiency and enhanced surgical precision.
Intuitive and convenient use on the iPad
ZEISS receives the 2012 NorthFace ScoreBoard Award for exceeding customer expectations
Carl Zeiss Meditec at the 2012 AAO-APAO Joint Meeting in Chicago
Modernized new OCT platforms span full spectrum of multi-modality imaging for glaucoma and retinal disease